Navigation Links
RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference
Date:3/17/2009

BOSTON, March 17 /PRNewswire/ -- RainDance Technologies, Inc., a privately held provider of innovative microdroplet-based solutions for human health and disease research, today announced it will be shipping its first commercial Sequence Enrichment Solution this month and reviewed the company's opportunities for growth at Cowen and Company's 29th Annual Health Care Conference.

The initial application of the company's RainStorm(TM) microdroplet-based technology platform focuses on targeted sequencing of the human genome, one of the fastest-growing segments of the rapidly expanding $1 billion DNA sequencing market. The company's Sequence Enrichment Solution and RDT 1000 system will enable the high-resolution analysis of genetic variation between individuals within populations at a level unmatched by current methodologies.

"We will make the first commercial shipment of our Sequence Enrichment Solution in March and presently have a backlog of orders," said Chris McNary, President and Chief Executive Officer, RainDance Technologies. "Over the next 3 years, we estimate the genomic sequence enrichment market at about $400 million, and we believe RainDance can capture a significant share."

During the last 6 months, RainDance has provided its solution to early access partners representing some of the world's leading genome research centers. These include the J. Craig Venter Institute, The Genome Center at the Washington University School of Medicine, and the Broad Institute. The company also collaborated with the Scripps Translational Science Institute to accelerate targeted genomic sequencing in its Wellderly Study of America's healthy elderly.

In targeted DNA sequencing applications, the Sequence Enrichment Solution provides researchers with higher resolution and statistical power while maximizing workflow efficiency and cost. "Our solution enables one next-generation sequencer to do what alternative technologies would require seven sequencers to complete in the same time," said McNary.

The company also reviewed the application of its RainStorm technology across a wide variety of growing life sciences and applied sciences markets.

"We have announced a consortium with sanofi aventis and Universite Louis Pasteur to develop the next generation of high-throughput screening and small molecule compound storage for drug discovery -- a $4 billion market," said McNary.

RainDance recently shared in a Massachusetts Life Sciences Center grant of $250,000 per year for 3 years to Dr. David Weitz, Mallinckrodt Professor of Physics and Applied Physics at Harvard's School of Engineering and Applied Sciences and Physics Department. The grant will fund research to develop a new form of fluorescence-activated cell sorter used to collect biochemical information about individual cells.

"We also have demonstrated proof of principle of our droplet-based technology in enzymatic detection of cell surface markers, sorting based on secreted proteins from cells, immunoassays, qPCR, and enzyme-directed evolution for industrial and biofuel applications," he said. "These studies highlight the potential of our RainStorm technology to become a true platform capable of sustaining growth for years to come."

About RainDance Technologies, Inc.

RainDance Technologies, Inc., is a provider of innovative microdroplet-based solutions for human health and disease research. The speed and simplicity of the company's exciting new technology platform enable researchers to design experiments in ways that were previously unaffordable or unimaginable. The company's RainStorm technology produces picoliter-volume droplets at a rate of 10 million per hour. Each droplet is the functional equivalent of an individual test tube and can contain a single molecule, reaction, or cell. This versatile technology can adapt proven assays for high-speed workflows with minimized process-induced bias or error.

RainDance was founded in 2004 by scientists from Harvard University; the Medical Research Centre in Cambridge, England and the ESPCI in Paris.

For more information, please visit www.raindancetech.com.

RainStorm(TM) is a trademark of RainDance Technologies, Inc.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Steven Becker

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78145


'/>"/>
SOURCE RainDance Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. RainDance Technologies and Harvard University to Share in First Massachusetts Life Sciences Center Cooperative Research Grants
2. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to The Genome Center at Washington University School of Medicine in St. Louis
3. RainDance Technologies to Present Workshop on Sequence Enrichment Using Innovative Microdroplet-Based Solutions at ASHG 2008
4. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
5. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI
6. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
7. RainDance Dedicates New Headquarters, Manufacturing Facility
8. RainDance Technologies to Dedicate New Headquarters, Manufacturing Facility in Lexington
9. RainDance and Scripps to Collaborate on Targeted Sequencing for Wellderly Study
10. RainDance Technologies Appoints Olex Vice President, System Development
11. RainDance Appoints Kelly Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces ... Clean Technology Fund I, LP and Clean Technology Fund ... venture capital funds which together hold approximately 59% of ... as converted basis), that they have entered into an ... in Biorem to TUS Holdings Co. Ltd. ("TUS") (en.tusholdings.com) ...
(Date:6/27/2016)... ... 27, 2016 , ... Rolf K. Hoffmann, former senior vice ... University of North Carolina Kenan-Flagler Business School effective June 27. , ... with a focus on the school’s international efforts, leading classes and participating in ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
(Date:4/14/2016)... TEL AVIV, Israel , April 14, 2016 /PRNewswire/ ... in Behavioral Authentication and Malware Detection, today announced the ... has already assumed the new role. Goldwerger,s ... for BioCatch, on the heels of the deployment of ... In addition, BioCatch,s behavioral biometric technology, which discerns unique ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):